An autopsy case of aggressive CD30+ extra-nodal NK/T-cell lymphoma initially manifested with granulomatous myositis

References

• Jaffe E S. Lymphoid lesions of the head and neck: a model of lymphocyte homing and lymphomagenesis. Modern Pathology 2002; 15: 225–263
   Web of Science ®Google Scholar
• Li C C, Tien H F, Tang J L, Yao M, Chen Y C, Su I J, et al. Treatment outcome and pattern of failure in 77 patients with sinonasal natural killer/T-cell or T-cell lymphoma. Cancer 2004; 100: 366–375
   PubMed Web of Science ®Google Scholar
• Jaffe E S, Harris N L, Stein H, Vardiman J W. Tumours of haematopoietic and lymphoid tissues. World Health Organization Classification of Tumours. IARC Press, Lyon 2001; 204–207
   Google Scholar
• Scarabello A, Leinweber B, Ardigo M, Rutten A, Feller A C, Kerl H, et al. Cutaneous lymphomas with prominent granulomatous reaction: a potential pitfall in the histopathologic diagnosis of cutaneous T- and B-cell lymphomas. American Journal of Surgical Pathology 2002; 26: 1259–1268
   PubMed Web of Science ®Google Scholar
• Dogan A, Burke J S, Goteri G, Stitson R N, Wotherspoon A C, Issacson P G. Micronodular T-cell/histiocyte-rich large B-cell lymphoma of the spleen. American Journal of Surgical Pathology 2003; 27: 903–911
   PubMed Web of Science ®Google Scholar
• Cerroni L. Cutaneous granulomas and malignant lymphomas. Dermatology 2003; 206: 78–80
   PubMed Web of Science ®Google Scholar
• Prayson R A. Granulomatous myositis. Clinicopathologic study of 12 cases. American Journal of Clinical Pathology 1999; 112: 63–68
   PubMed Web of Science ®Google Scholar
• Mantegazza R, Bernasconi P. Cellular aspects of myositis. Current Opinions in Rheumatology 1994; 6: 568–574
   PubMedGoogle Scholar
• Antonioli C M, Airo P. Dermatomyositis associated with lymphoproliferative disorder of NK cells and occult small cell lung carcinoma. Clinical Rheumatology 2004; 23: 239–241
   PubMed Web of Science ®Google Scholar
• Drut R, Drut R M. Angiocentric immunoproliferative lesion and angiocentric lymphoma of lymph node in children. Journal of Clinical Pathology 2005; 58: 550–552
   PubMed Web of Science ®Google Scholar
• Natkunam Y, Warnke R A. Angiocentric lymphomas (lymphomatous vasculitis). Seminars in Diagnostic Pathology 2001; 18: 67–77
   PubMed Web of Science ®Google Scholar
• Bekkenk M W, Jansen P M, Meijer C J, Willemze R. CD56+ hematological neoplasms presenting in the skin: a retrospective analysis of 23 new cases and 130 cases from the literature. Annals of Oncology 2004; 15: 1097–1108
   PubMed Web of Science ®Google Scholar
• Krenacs L, Wellmann A, Sorbara L, Himmelmann A W, Bagdi E, Jaffe E S, et al. Cytotoxic cell antigen expression in anaplastic large cell lymphomas of T- and null-cell type and Hodgkin's disease: evidence for distinct cellular origin. Blood 1997; 89: 980–989
   PubMed Web of Science ®Google Scholar
• Felgar R E, Salhany K E, Macon W R, Pietra G G, Kinney M C. The expression of TIA - 1+ cytolytic-type granules and other cytolytic lymphocyte-associated markers in CD30+ anaplastic large cell lymphomas (ALCL): correlation with morphology, immunophenotype, ultrastructure, and clinical features. Human Pathology 1999; 30: 228–236
   PubMed Web of Science ®Google Scholar
• Foss H -D, Anagnostopoulos I, Araujo I, Assaf C, Demel G, Kummer J A, et al. Anaplastic large-cell lymphomas of T-cell and null-cell phenotype express cytotoxic molecules. Blood 1996; 88: 4005–4011
   PubMed Web of Science ®Google Scholar
• Suzuki R, Kagami Y, Takeuchi K, Kami M, Okamoto M, Ichinohasama R, et al. Prognostic significance of CD56 expression for ALK-positive and ALK-negative anaplastic large-cell lymphoma of T/null cell phenotype. Blood 2000; 96: 2993–3000
   PubMed Web of Science ®Google Scholar
• Chiarle R, Podda A, Prolla G, Gong J, Thorbecke G J, Inghirami G. Molecule of the month: CD30 in normal and neoplastic cells. Clinical Immunology 1999; 90: 157–164
   PubMed Web of Science ®Google Scholar
• Horie R, Watanabe T. CD30: expression and function in health and disease. Seminars in Immunology 1998; 10: 457–470
   PubMed Web of Science ®Google Scholar
• Younes A, Aggarwall B B. Clinical implications of the tumor necrosis factor family in benign and malignant hematologic disorders; a short review. Cancer 2003; 98: 458–467
   PubMed Web of Science ®Google Scholar
• Bergman R, Marcus-Farber B S, Manov L, Nerodinisky I, Epelbaum R, Sahar D, et al. Clinicopathologic reassessment of non-mycosis fungoides primary cutaneous lymphomas during 17 years. International Journal of Dermatoogy 2002; 41: 735–743
   PubMed Web of Science ®Google Scholar
• Chang S E, Yoon G S, Huh J, Choi J H, Sung K J, Moon K C, Koh J K. Comparison of primary and secondary cutaneous CD56+ NK/T cell lymphomas. Applied Immunohistochemistry & Molecular Morphology 2002; 10: 163–170
   Web of Science ®Google Scholar
• Gaal K, Sun N C, Hernandez A M, Arber D A. Sinonasal NK/T-cell lymphomas in the United States. American Journal of Surgical Pathology 2000; 24: 1511–1517
   PubMed Web of Science ®Google Scholar
• Wechsler J, Willemze R, van der Brule A, Thomine E, Joly P, Verola O, et al. Differences in Epstein-Barr virus expression between primary and secondary cutaneous angiocentric lymphomas. French Study Group of Cutaneous Lymphomas. Archives of Dermatology 1998; 134: 479–484
   PubMed Web of Science ®Google Scholar
• Allory Y, Challine D, Haioun C, Copie-Bergman C, Delfau-Larue M H, Boucher E, et al. Bone marrow involvement in lymphomas with hemophagocytic syndrome at presentation: a clinicopathologic study of 11 patients in a Western institution. American Journal of Surgical Pathology 2001; 25: 865–874
   PubMed Web of Science ®Google Scholar
• Mori K L, Egashira M, Oshimi K. Differentiation stage of natural killer cell-lineage lymphoproliferative disorders based on phenotype analysis. British Journal of Haematology 2001; 115: 225–228
   PubMed Web of Science ®Google Scholar
• Tao J, Shelat S G, Jaffe E S, Bagg A. Aggressive Epstein-Barr virus-associated, CD8+, CD30+, CD56+, surface CD3−, natural killer (NK)-like cytotoxic T-cell lymphoma. American Journal of Surgical Pathology 2002; 26: 111–118
   PubMed Web of Science ®Google Scholar